Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels-Reference-Cited by-同舟云学术

Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels

Published:2015-05 Issue: Volume:18 Page:163-169
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Ezhov M.V.,Safarova M.S.,Afanasieva O.I.,Pogorelova O.A.,Tripoten M.I.,Adamova I.Y.,Konovalov G.A.,Balakhonova T.V.,Pokrovsky S.N.

Funder

Moscow State Government

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference28 articles.

1. European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status;Nordestgaard;Eur Heart J,2010

2. Relation Between Lipoprotein(a) and Fibrinogen and Serial Intravascular Ultrasound Plaque Progression in Left Main Coronary Arteries;Hartmann;J Am Coll Cardiol,2006

3. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction;Kamstrup;JAMA,2009

4. Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality;Erqou;JAMA,2009

5. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study;Kronenberg;Circulation,1999

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Special Patient Populations;Clinical Lipidology;2024

2. Lipoprotein (a) in atherosclerosis: A bibliometric and visualization analysis;Vascular Investigation and Therapy;2023-10

3. Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a);Current Atherosclerosis Reports;2023-06-05

4. Lipoprotein apheresis improves intima media thickness regression: Evidence in the era of new lipid-lowering therapies;Transfusion and Apheresis Science;2023-02

5. Barbarians at the Gate: Vascular Age as an Opportunity to Timely Prevent Atherosclerotic Cardiovascular Disease;Journal of Clinical and Preventive Cardiology;2023-01